FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/077197 [Registered on: 21/11/2024] Trial Registered Prospectively
Last Modified On: 20/11/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effectiveness of Dural Tube Myofascial Release in Cervicogenic Headache: Randomized Controlled Trial 
Scientific Title of Study   Effectiveness of Dural Tube Myofascial Release on Suboccipital Muscle Thickness, Cervical Flexion-Rotation Range & Clinical Metrics For Cervicogenic Headache: Randomized Controlled Trial  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Aarti Welling 
Designation  Associate Professor 
Affiliation  KLE Institute of Physiotherapy 
Address  KLE Institute of Physiotherapy, Nehru Nagar, Belagavi, Karnataka, India
KLE Dr. Prabhakar Kore Hospital and MRC, Physiotherapy Department, Nehru Nagar, Belagavi, Karnataka, India
Belgaum
KARNATAKA
590010
India 
Phone    
Fax    
Email  aartiwell88@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vijay Kage 
Designation  Professor 
Affiliation  KLE Institute of Physiotherapy 
Address  KLE Institute of Physiotherapy, Nehru Nagar, Belagavi, Karnataka, India
KLE Dr. Prabhakar Kore Hospital and MRC, Physiotherapy Department, Nehru Nagar, Belagavi, Karnataka, India
Belgaum
KARNATAKA
590010
India 
Phone  9845271899  
Fax    
Email  vijaykage@yahoo.in  
 
Details of Contact Person
Public Query
 
Name  Aarti Welling 
Designation  Associate Professor 
Affiliation  KLE Institute of Physiotherapy 
Address  KLE Institute of Physiotherapy, Nehru Nagar, Belagavi, Karnataka, India
KLE Dr. Prabhakar Kore Hospital and MRC, Physiotherapy Department, Nehru Nagar, Belagavi, Karnataka, India
Belgaum
KARNATAKA
590010
India 
Phone  9448814569  
Fax    
Email  aartiwell88@gmail.com  
 
Source of Monetary or Material Support  
KLE Dr Prabhakar Kore Hospital and MRC, Belagavi, Karnataka, India, 590010 
 
Primary Sponsor  
Name  Aarti Welling 
Address  KLE Institute of Physiotherapy, Nehru Nagar, Belagavi, Karnataka, 590010, India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aarti Welling  KLE Dr. Prabhakar Kore Hospital and MRC  Department of Physiotherapy, Room no 18, Nehru Nagar, Belagavi, Karnataka, 590010, India
Belgaum
KARNATAKA 
9448814569

aartiwell88@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
KAHER Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M95-M95||Other disorders of the musculoskeletal system and connective tissue,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Dural Tube Release  Dural Tube release given for a duration of 4 weeks on alternate days followed by SNAGs and Low Load Exercise 
Comparator Agent  SNAGs and Low Load exercise   SNAGs will be given for 4 weeks on alternate days followed by home exercise protocol that is low load exercises for 12 weeks 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1. Individuals diagnosed with CGH based on the CHISG with a mandatory presentation of unilaterality of the head pain without side-shift associated with the neck pain and positive flexion-rotation test less then 33 degrees.31
2.All gender individuals aged 18-50 years.
3.Willingness to participate in the intervention while continuing to follow up for 12 weeks.
 
 
ExclusionCriteria 
Details  1.Primary headache according to ICHD.9
2.Exhibiting any red flags for manual therapy15 like spinal infection, vertebral tumors or fracture, cervical instability, metabolic diseases, rheumatoid arthritis, osteoporosis, dizziness or visual disturbance symptoms, skin inflammatory condition, ulcers or wounds around treatment area.
3.Any medical or surgical conditions that prevents the participants from going in prone position as it is required for the intervention.
4.Taking prescribed analgesics or physiotherapy or any other allied therapies for the treatment of headache/ cervical pain/ or any other condition within 1 month.
5. Radiating pain in the upper extremity/neurological deficits to the upper extremities or known cases of cervical disc condition, arthritis of the cervical spine.
6.History of central nervous system involvement and vestibular dysfunction.
7.History of prior surgery to the head or neck.
8.Pregnancy.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
1. Suboccipital Muscle thickness assessment using ultrasonography
2. Flexion Rotation Test 
Baseline and Post intervention (4 weeks) 
 
Secondary Outcome  
Outcome  TimePoints 
1. Intensity, Duration and Frequency
2. Quality of life 
Baseline and Post Intervention (4 weeks, 6 weeks and 8 weeks) 
 
Target Sample Size   Total Sample Size="34"
Sample Size from India="34" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   18/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="4"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Cervicogenic headache (CGH) is commonly linked to physical impairments in the joints, muscles and neural structures of the cervical region, particularly the upper spine. Due to the referral of pain from the neck, CGH is frequently misdiagnosed and overlooked in individuals experiencing neck pain, leading to inadequate treatmentPhysiotherapy is a safe and effective alternative, employing manual therapy techniques and highlighting the fascial concept to tackle neuro-musculoskeletal conditions linked to cervicogenic headaches.
Various systematic reviews favour the use of sustained natural apophyseal glides (SNAGs) as a part of non-pharmacological management of cervicogenic headache. The clinical practice guidelines suggest that SNAGs and low load cervical exercises can be considered as a standard line of management for cervicogenic headache. However the potential effect of SNAGS and low load exercises on cervical muscle dysfunction visualized based on cervical muscle thickness in relation to the myodural bridge or dura using ultrasonography is seldom studied, there is also lack of supporting evidence considering the carry over effect  of these techniques on the clinical metrics of cervicogenic headache. 
Application of Myofascial release (MFR) techniques like trigger point therapy and suboccipital release in reducing the intensity of CGH has been researched with positive outcomes. However none of these techniques targeted the dural tube that is a potential factor for CGH, that would have an impact on muscle thickness connecting the dural tube. 
Considering the dural tube being a major contributing factor for CGH which is linked through fascia of suboccipital muscles, the potential effect of fascial techniques like dural tube MFR that are specifically targeting the bridge and dura on clinical metrics (intensity, frequency, duration & severity) and muscle thickness is unknown and not explored. Thus it was hypothetized to determine and compare the effect of dural tube myofascial release with Sham release along with standard physical therapy care on suboccipital muscle thickness, cervical flexion-rotation range and clinical metric of headache in individuals with cervicogenic headache.
 
Close